A leukotriene receptor antagonist modulates iNOS in the lung and in a leukotriene-free cell model

Nitric Oxide - Biology and Chemistry

Volumn 9, Issue 1, 2003, Pages 10-17

  Offer, Sarit ^a,b   Shoseyov, David ^c   Bibi, Haim ^d   Eliraz, Abraham ^b   Madar, Zecharia ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b KAPLAN HOSPITAL   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

BN rats; Cytokines; Leukotriene receptor antagonist; Nitric oxide; Respiratory epithelial cells

Indexed keywords

ALLERGEN; BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; NITRIC OXIDE SYNTHASE; NITRITE; OVALBUMIN; PEPTIDOLEUKOTRIENE; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME INDUCTION; EXPERIMENTAL MODEL; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; INHALATION; INJECTION; INTERMETHOD COMPARISON; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG FLUID; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; RAT; SUPERNATANT; WESTERN BLOTTING;

RATTUS NORVEGICUS;

EID: 0141892583     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-8603(03)00047-8     Document Type: Article

References (36)

1. Watkins D.N., Peroni D.J., Basclain K.A., Garlepp M.J., Thompson P.J. Expression and activity of NOS in human airway epithelium. Am. J. Resp. Cell Mol. Biol. 16:1997;629-639.
2. Kharitonov S.A., Yates D.H., Robbins R.A., Logan-Sinclair R., Shinebourne E.A., Barnes P.J. Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 343:1994;133-135.
3. De Sanctis G.T., Maclean J.A., Hamada K.et al. Contribution of nitric oxide synthase 1,2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma. J. Exp. Med. 189:1999;1621-1629.
4. Belvisi M., Barnes P.J., Larkin S., Yacoub M., Tadjkarimi S., Williams T.J., Mitchell J.A. Nitric oxide synthase activity is elevated in inflammatory lung disease in humans. Eur. J. Pharmacol. 283:1995;255-258.
5. Du T., Xu L.J., Lei M., Wang N.S., Eidelman D.H., Ghezzo H., Martin J.G. Morphometric changes during the early airways response to allergen challenge in the rat. Am. Rev. Resp. Dis. 146:1992;1037-1041.
6. Eidelman D.H., Bellofiore S., Martin J.G. Late airway responses to antigen challenge in sensitized inbred rats. Am. Rev. Resp. Dis. 137:1988;1033-1037.
7. Pauwels R., Bazin H., Plateau B., Van der Straeten M. The influence of antigen dose on IgE production in different rat strains. Immunology. 36:1979;151-157.
8. Renzi P.M., Sebastiao N., Assaad A.S., Giaid A., Hamid Q. Inducible nitric oxide synthase mRNA and immunoreactivity in the lungs of rats eight hours after antigen challenge. Am. J. Resp. Cell Mol. Biol. 17:1997;36-44.
9. Hoffman G., Grote J., Friedrich F., Mutz N., Schobersberger W. The pulmonary epithelial cell line L2 as a new model for an inducible nitric oxide synthase expressing distal airway epithelial cell. Biochem. Biophys. Res. Commun. 217:1995;575-583.
10. Wei-Yi S., Day B.J., Kang B.H., Crapo J.D., Huang Y.C.T., Chang L.Y. Lung epithelial cell-released nitric oxide protects against PMN-mediated cell injury. Am. J. Physiol. 271:1996;581-586.
11. Thompson D.C., Porter S.E., Bauer A.K., Das K.C., Ou B., Dwayer-Nield L., White C.W., Malkinson A.M. Cytokine induced nitric oxide formation in normal but not in neoplastic murine lung epithelial cell lines. Am. J. Physiol. 274:1998;922-932.
12. Kwon S., George S.C. Synergistic cytokine induced nitric oxide production in human alveolar epithelial cells. Nitric Oxide: Biol. Chem. 3:1999;348-357.
13. G.P. Geba, R.J. Zitnik, J.A. Elias, Interleukines in the pulmonary inflammatory response, in: P.J. Barnes, R.A. Stockly (Eds.), Blackwell, Oxford, 1994, pp. 314-343.
14. Busse W.W. Leukotrienes and inflammation. Am. J. Respir. Crit. Care Med. 157:1998;210-213.
15. Robidoux C., Maghni K., Laporte J., Ponton A., Hallee A., Borgeat P., Sirois P. Highly purified guinea pig type II pneumoctes have the leukotriene A4 hydrolase but do not express 5-lipoxygenase activity. Prostaglandins Leukot. Essent. Fatty acids. 51:1994;263-270.
16. 2 metabolites regulate inducible nitric oxide synthase in myocytes. Hypertension. 31:1998;218-224.
17. Renzi P.M., Olivenstein R., Martin J.G. Effect of dexamethasone on airway inflammation and responsiveness after antigen challenge of the rat. Am. Rev. Resp. Dis. 948:1993;932-939.
18. Reiss T.F., Chervinsky P., Dockhorn R.J., Shingo S., Seidenberg B., Edwards T.B. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multi center, randomized, double blind trial. Arch. Intern. Med. 158:1998;1213-1220.
19. Hamelmann E.J., Schwarze K., Takeda A., Oshiba G.L., Larsen C.G.I., Gelfand E.W. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Resp. Crit. Care Med. 156:1997;766-775.
20. Thomsen L.L., Miles D.W. Role of nitric oxide in tumor progression: lessons from human tumors. Can. Met. Rev. 17:1998;107-118.
21. Crespo E., Macias M., Pozp D., Escames G., Martin M., Vives F., Guerro J.M., Castroviejo D.A. Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide induced multiple organ dysfunction syndrome in rats. FASEB J. 13:1999;1537-1546.
22. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate,nitrite and 15N nitrate in biological fluids. Anal. Biochem. 126:1982;131-138.
23. 4 receptor antagonist. Can. J. Physiol. Pharmacol. 73:1995;191-201.
24. Jarvis B., Markham A. Montelukast. A review of its therapeutic potential in persistent asthma. Drugs. 59:2000;891-928.
25. Bratton D.L., Lanz M.J., Miyazawa N., White C.W., Silkoff P.E. Exhaled nitric oxide before and after Montelukast sodium therapy in school age children with chronic asthma: a preliminary study. Ped. Pulm. 28:1999;402-407.
26. Salmon M., Walsh D.A., Huang T.J., Barnes P.J., Leonard T.B., Hay D.W.P., Chung K.F. Involvement of cysteinyl leukotrienes in airway smooth muscle cell DNA synthesis after repeated allergen exposure in sensitized Brown Norway rats. Br. J. Pharmacol. 127:1999;1151-1158.
27. Cadogen E., Hopkins N., Giles S., Bannigan J.G., Moynihan J., Mcloughlin P. Enhanced expression of nitric oxide synthase without vasodilator effect in chronically infected lungs. Am. J. Physiol. 277:1999;616-627.
28. Lovechik J., Lipscomb M., Lyons C.R. Expression of lung iNOS protein does not correlate with NO production in vivo in a pulmonary immune response against Cryptococcus neoforms. J. Immunol. 158:1997;1772-1778.
29. 4. Potentiation of inflammation. Am. J. Resp. Cell Mol. Biol. 23:2000;572-577.
30. Walch L., Norel X., Gascard J.P., Brink C. Functional studies of leukotriene receptors in vascular tissues. Am. J. Resp. Crit. Care Med. 161:2000;107-111.
31. Ihaku D., Cameron L., Suzuki M., Molet S., Martin J., Hamid Q. Montelukast a leukotriene receptor antagonist, inhibits the late airway response to antigen, airway eosinophilia, and IL-5 expressing cells in Brown Norway rats. J. Allergy Clin. Immunol. 104:1999;1147-1154.
32. Virchow J.C., Faehndrich J.R.C., Nassenstein C., Bock S., Matthys H., Luttmann W. Effect of a specific cysteinyl leukotriene receptor 1-antagonist (montelukast) On the transmigration of eosinophils across human umbilical vein endothelial cells. Clin. Exp. Allergy. 31:2001;836-845.
33. Amrany Y., Moore P.E., Hoffman R., Shore S.A., Panettieri R.A. Interferon modulates cysteinyl leukotriene receptor-1 expression and function in human airway myocytes. Am. J. Crit. Care Med. 164:2001;2098-2101.
34. Behera A.K., Kumar M., Matsuse H., Lockey R.F., Mohapatra S.S. Respiratory syncytial virus induces the expression of 5-lipoxygenase and endothelin 1-in bronchial epithelial cells. Biochem. Biophys. Res. Commun. 251:1998;704-709.
35. Bonizzi G., Piette J., Merville M.P.et al. Distinct signal transduction pathways mediate Nuclear Factor kB induction by IL-1β in epithelial and lymphoid cells. J. Immunol. 159:1997;5264-5272.
36. Coffey M.J., Phare S.M., Peters-Golden M. Prolonged exposure to lipopolysaccharide inhibits macrophage 5-lipoxygenase metabolism via induction of Nitric Oxide Synthase. J. Immunol. 165:2000;3592-3598.